Recursive Adaptation - Addiction Medicine and Policy

Recursive Adaptation - Addiction Medicine and Policy

Home
CASPR.org
Archive
About
"Post-GLP-1 shot, I could physically feel the desire cravings leave my head."
A shopping addiction and alcohol addiction disappeared with semaglutide.
 • 
Noah Davis
Cannabis and psychosis, PRV for addiction, vaping, and endpoints
Addiction news and updates
 • 
Nicholas Reville
2
Do GLP-1s reduce drug or alcohol withdrawal symptom severity?
5 stories from patients.
 • 
Noah Davis

March 2025

February 2025

Semaglutide compounding is being shut down– can a gummies hack keep it alive?
And will patients turn on Trump and RFK as hundreds of thousands lose access to GLP-1s?
 • 
Nicholas Reville
1
New discussion list for SUD professionals working with GLP-1s
Be in touch if you would like to join.
 • 
Nicholas Reville
Ozempic (semaglutide) shows huge reductions in high-risk heavy drinking, in first-ever clinical trial
Powerful findings in Christian Hendershot's RCT w/ 48 non-treatment seekers and relatively low doses of semaglutide.
 • 
Nicholas Reville
4
Suzetrigine approved, AUD endpoints might be updated?, and more addiction news
Has the FDA already updated AUD qualified endpoints but can't say so yet?
 • 
Nicholas Reville
One of the most important GLP-1 for addiction trials has just begun (and needs another site)
Sue Grigson's trial is looking at semaglutide for OUD-- and they urgently need support to add more patients.
 • 
Nicholas Reville
1

January 2025

© 2025 CASPR
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture